205 Recruiting Trials

Clinical Trials in Hawaii

Browse 205 recruiting clinical trials currently enrolling participants in Hawaii. Search by condition to find trials you may qualify for — at no cost.

Showing 15 of 205 recruiting trials in Hawaii

Connect for Cancer Prevention Study (Connect)
N/A Denver, Colorado +4 sites · Cancer, General Research Use
Recruiting
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
PHASE2 Little Rock, Arkansas +4 sites · Medulloblastoma
Recruiting
Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma
PHASE2 Honolulu, Hawaii · Hepatocellular Carcinoma Non-resectable
Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
PHASE2 Birmingham, Alabama +4 sites · Neuroblastoma, High-risk Neuroblastoma
Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
PHASE1 Birmingham, Alabama +4 sites · Osteosarcoma, Neuroblastoma
Recruiting
Patient Retrospective Outcomes (PRO)
N/A Lake Havasu City, Arizona +4 sites · Chronic Pain
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Recruiting
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
PHASE2 Anchorage, Alaska +4 sites · Resectable Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma
Recruiting
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
PHASE3 Birmingham, Alabama +4 sites · Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
PHASE3 Birmingham, Alabama +4 sites · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
PHASE2 Phoenix, Arizona +4 sites · Muscle Invasive Bladder Urothelial Carcinoma, Stage IV Bladder Urothelial Carcinoma AJCC v7
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
PHASE3 Jonesboro, Arkansas +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
PHASE3 Tucson, Arizona +4 sites · Endometrial Cancer
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
N/A Athens, Alabama +4 sites · Lumbar Spinal Stenosis
Recruiting
See all 205 results in Hawaii

Check Your Eligibility

Create a free profile and our AI will match you to trials in Hawaii you may qualify for.

Get Matched — Free
No insurance required
Search by Condition in Hawaii
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
Browse Other States
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon